• Home
  • Topics
    • Health Insurance Coverage
    • Medicare
    • Medicaid and CHIP
    • Blue Cross Blue Shield
    • Health Insurance Companies
    • Prescription Drugs and Pharmacy
    • Healthcare Policy and Law
    • Hospitals and Health Systems
    • Healthcare Business
    • Health Technology and AI
    • Senior Care
    • Public Health and Research
  • Guides
    • All Health Insurance Guides
    • Choosing a Health Insurance Plan
    • Individual Health Insurance
    • Family Health Insurance
    • High Deductible Health Plans
    • Short-Term Health Insurance
    • Self-Employed Health Insurance
    • Student Health Insurance
    • Low Income Health Insurance
    • Health Sharing Plans
  • Insurance Company List
  • About Us

Health Plan News

Timely Health Plan News and Commentary

Health Plan News
Home Archives for Public Health and Research

Public Health and Research News

Public health is the work of protecting the health of entire populations rather than individual patients: tracking disease, preventing outbreaks, promoting vaccination and screening, and studying what actually improves health outcomes. Research findings and public health data also drive coverage decisions, because health plans and regulators rely on evidence when they decide which services, screenings and treatments to cover.

What We Cover

This section covers public health developments and medical research with consequences for patients and health plans. That includes infectious disease, including COVID-19 and influenza; chronic conditions such as diabetes, heart disease, obesity and cancer; Alzheimer's disease and dementia; mental health and substance use; maternal and child health; and studies on health care costs, outcomes and access. We report on guidance from the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), and on peer-reviewed research and survey data.

How We Report Research

A single study rarely settles a question. When we report research, we identify who conducted and funded it, how large it was, and whether the findings are preliminary. This content is news and general information; it is not medical advice, and readers should discuss treatment decisions with a licensed clinician.

Research and public health news connects to our other sections. Drug approvals and vaccine coverage appear in Prescription Drugs and Pharmacy, preventive services coverage appears in Health Insurance Coverage, public health policy appears in Healthcare Policy and Law, and research on aging appears in Senior Care.

The latest public health and research news appears below, newest first.

Community-Based Lifestyle Intervention Yields Weight Loss, Reduced Glucose Results Similar to Those in DPP

Posted on June 29, 2010 Written by Editor

SOURCE: American Diabetes Association

ORLANDO, FL–(Marketwire – June 29, 2010) –  A community-based lifestyle intervention program, modeled after one used in a landmark government funded diabetes-prevention study, can help participants in a group setting achieve weight loss and blood glucose reductions comparable to those achieved with individual counseling from health professionals, according to data presented by researchers at the American Diabetes Association’s 70th Scientific Sessions®.

In the Healthy Living Partnerships to Prevent Diabetes (HELP PD) study, participants were divided into two groups: a lifestyle weight loss group, which received six months of weekly behavioral weight loss sessions in a group setting, followed by monthly follow-up meetings, at which they were encouraged to change eating behaviors and exercise up to 180 minutes per week; and a usual care group, which received two visits with a dietitian and a quarterly newsletter with tips for lifestyle changes. The group weight loss sessions were delivered by lay community health workers trained and supervised by dietitians at the Wake Forest Diabetes Care Center in Winston-Salem, North Carolina.

The study found that those in the lifestyle intervention group achieved and maintained significantly greater weight loss (an average of 7.3 percent of body weight) than those in the regular care group (who achieved an average loss of just 1.3 percent of body weight) after 12 months. The lifestyle intervention group also reduced blood glucose levels by an average of over 4 mg/dl, from 105.8 mg/dl to 101.2 mg/dl, after 12 months, compared to an average drop of less than 2 mg/dl (to 104 mg/dl) for the regular care group. The results for the lifestyle group mirrored those achieved over three years by participants in the landmark National Institutes of Health-sponsored Diabetes Prevention Program, in which individuals with glucose levels in the pre-diabetic range were able to reverse the course of their disease by losing 5-7% of body weight and exercising 150 minutes per week, in addition to receiving individual counseling sessions with trained behavioralists. In the Diabetes Prevention Program, the weight loss program led to a 58% reduction in the development of diabetes, from about 11% a year to about 5% a year.

“In the Diabetes Prevention Program, professional behavioral specialists worked with participants with pre-diabetes in one-on-one sessions. We trained some of our patients with diabetes to work as lay community health workers with groups of participants with pre-diabetes, so we really didn’t expect to see quite as good a weight loss result as we did, but we were very pleased to see it,” said David Goff, MD, Chair of the Department of Epidemiology and Prevention at Wake Forest University School of Medicine, and lead researcher on the study. “Given that our weight loss results look as good as the DPP, this approach shows great promise for preventing diabetes. It’s a very translatable intervention to deliver in public health settings. We think this approach could be replicated at Diabetes Care Centers across the country.”

There are more than 3,000 such centers in the United States, with on-site physicians, diabetes educators and facilities that can be used for delivering the type of group intervention employed in this study. However, the intervention can be delivered in any setting where community health workers have access to a room large enough for about a dozen people to meet, a television, a DVD player, and a scale, Dr. Goff said.

The HELP PD model relies upon DVDs developed by the research team that give participants information about healthy eating, proper stretching and exercise tips, how to eat “mindfully” (i.e. not out of boredom or habitually in front of the television) and other lifestyle-related topics. Dr. Goff said that training community health workers to coach participants on how to set goals, solve problems and use the information in the DVDs could be accomplished by others interested in starting such a program in their own community. Reimbursement for these programs is a barrier.

Study participants will be followed for an additional five years to see whether individuals can maintain weight loss and blood glucose reductions independently, or if they need continued group counseling to do so. The study is being funded by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

HELP PD is one of numerous community-centered intervention models being developed based upon a program used during the DPP. Several different programs, tested in a variety of community settings, will be discussed and presented during the Association’s 70th Scientific Sessions, including the Group Lifestyle Balance Program, which helped significantly reduce diabetes risk factors through group settings at a primary care practice in California and also through DVDs that could be viewed at home (105-OR). This program was also successful when delivered by diabetes educators (417-PP). Another focused on Arab Americans in the Detroit, Michigan area, who successfully reached weight loss and physical activity goals through a program culturally modified to suit Middle Eastern diet and values (110-OR). And African Americans recruited during Sunday services at 42 churches in Georgia and Connecticut showed promising initial weight loss and a high willingness to participate in a church-based, culturally adapted lifestyle change program, according to preliminary data (109-OR).

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Oral Presentation, Tuesday, June 29, 8:25 a.m.

Contact:
Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Public Health and Research

HHS Secretary Sebelius to Join Leaders From NIH, FDA and Academia to Discuss New Roles in Drug Discovery and Development

Posted on June 29, 2010 Written by Editor

SOURCE: Ewing Marion Kauffman Foundation

KANSAS CITY, MO–(Marketwire – June 29, 2010) –  U.S. Secretary of Health and Human Services Kathleen Sebelius and other national leaders are coming together on July 6, 2010 for a first-of-its-kind town hall-style meeting with the goal of accelerating the discovery and development of new cancer drugs.

The event will bring together other senior government officials and thought leaders from industry, venture capital, academia, venture philanthropy and non-profit sectors to spur innovation and move discoveries more quickly from the laboratory to the clinic, where they can benefit patients battling cancer. Francis Collins, director of the National Institutes of Health, Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, and Richard Gephardt, former U.S. House Majority Leader and Chairman of the Council for American Medical Innovation, are among those who will participate.

Reflecting the growing shift away from the model of large pharmaceutical companies developing drugs internally from start to finish, the town hall is titled, “The New Role of Academia in Drug Discovery and Development.” It is being sponsored by Friends of Cancer Research and the University of Kansas Cancer Center, with support from the Kansas Bioscience Authority, Ewing Marion Kauffman Foundation and Council for American Medical Innovation.

Where: The Kauffman Foundation Conference Center, 4801 Rockhill Road, Kansas City, Mo., 64110

When: July 6, 2010, 7:45 a.m. – 3:45 p.m. CDT

Many key participants and organizational leadership will be available for press prior to the conference.

Press Contacts:
Friends of Cancer Research: Ryan Hohman, [email protected] or 717-333-6248

The University of Kansas Cancer Center: Marci Nielsen, [email protected], 913-961-0759 or Stephanie Sharp, [email protected], 913-579-4376

Kansas Bioscience Authority: Chad Bettes, [email protected] or 913-397-8300

Kauffman Foundation: Barb Pruitt, [email protected] or 816-932-1288

Council for American Medical Innovation: Sean Donahue, [email protected] or 202-347-7947

About Friends of Cancer Research

Friends of Cancer Research (Friends) is a cancer research think tank based in the Washington, D.C. area. Working with the entire cancer research and advocacy community, Friends pioneers innovative public-private partnerships, organizes critical policy forums, educates the public, and brings together key stakeholders to overcome the barriers standing between patients and the most promising cancer treatments.

About The University of Kansas Cancer Center

At The University of Kansas Cancer Center, we are more than an academic cancer center; we are a unique community-based cancer research and care partnership focused on one mission: eliminating the burden of cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program.

About the Ewing Marion Kauffman Foundation

The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. 

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, investment, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America’s economic recovery, future prosperity and health.

About the Kansas Bioscience Authority

The KBA is a $581 million initiative that is advancing Kansas’ national bioscience leadership by building world-class research capacity; fostering the formation and growth of bioscience startups; supporting expansion of the state’s bioscience clusters; and facilitating industrial expansion and attraction.

Press Contacts:
Friends of Cancer Research:
Ryan Hohman
[email protected]
717-333-6248

The University of Kansas Cancer Center:
Marci Nielse
[email protected]
913-961-0759

Stephanie Sharp
[email protected]
913-579-4376

Kansas Bioscience Authority:
Chad Bettes
[email protected]
913-397-8300

Kauffman Foundation:
Barb Pruitt
[email protected]
816-932-1288

Council for American Medical Innovation:
Sean Donahue
[email protected]
202-347-7947

Click here to see all recent news from this company

Filed Under: Prescription Drugs and Pharmacy, Public Health and Research

Diabetes Drug Rosiglitazone Not Associated With Increased Risk of Death, Stroke or Heart Attacks in BARI 2D Study

Posted on June 28, 2010 Written by Editor

SOURCE: American Diabetes Association

Study Confirms Higher Incidence of Fractures

ORLANDO, FL–(Marketwire – June 28, 2010) –  Rosiglitazone, a commonly used diabetes drug, poses no significant increased risk of death, stroke or heart attack, though it does increase the risk of fractures, according to a new analysis of thousands of patients with established cardiovascular disease and type 2 diabetes. The findings are being presented at the American Diabetes Association’s 70th Scientific Sessions®, and are part of the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) study, a landmark multicenter trial focusing exclusively on patients with both diabetes and established heart disease.

The safety of rosiglitazone, marketed as Avandia, a medication in the class of thiazolidinedione (TZD) drugs, has been a controversial topic since a 2007 meta-analysis published in the New England Journal of Medicine concluded that rosiglitazone “was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes.” The strength of this study, which reviewed the results of 42 previously published investigations but did no independent testing of the drug, has been questioned by others in the field but ultimately led to a review of the drug’s safety by the U.S. Food and Drug Administration (FDA). In November 2007, the FDA added a warning label to the drug regarding potential heart risks.

The following year, however, researchers conducting the Veterans Affairs Diabetes Trial (VADT), a large-scale clinical trial in which 80 percent of patients were taking rosiglitazone, added further, while still inconclusive, information to this discussion. During the American Diabetes Association’s 68th Scientific Sessions, the VADT researchers reported that a specific analysis of rosiglitazone found that it did not appear to cause excess cardiovascular events and may in fact provide protective benefits for cardiovascular health.

Now a post-hoc analysis of the BARI 2D findings also shows no increased risk of heart attack or cardiovascular death with rosiglitazone treatment. Analyzing 4.5 years of follow-up data for patients who were being treated with rosiglitazone, compared to those not taking any TZD drugs, the study found no increase in risk of death or heart attack from taking rosiglitazone. While no protective cardiovascular benefit was shown, the analysis found that the rate of death, heart attack and stroke tended to be lower — about 28 percent lower in fact — among patients taking rosiglitazone. As has been seen with other studies of TZDs, the rate of congestive heart failure was significantly higher among patients taking rosiglitazone, but this difference was not statistically significant. 

As seen in previous studies, the analysis of BARI 2D reported a 45 percent increase in fracture rates for those taking rosiglitazone, compared to those not taking any TZD medications.

“I think these data are important because they suggest there is no significant cardiovascular harm posed by taking rosiglitazone for patients with type 2 diabetes and coronary heart disease,” said lead researcher Richard Bach, M.D., Associate Professor of Medicine at the Washington University School of Medicine. “There is an increase in fractures, but when one considers the dramatic morbidity and mortality associated with ischemic cardiovascular events in patients with diabetes, these data are reassuring.”

The BARI 2D study, led by principal investigator Sheryl Kelsey, Ph.D, of the University of Pittsburgh Graduate School of Public Health, evaluated both a cardiovascular treatment approach as well as a diabetes control approach in 2,368 persons with type 2 diabetes and stable coronary artery disease (CAD) to reduce deaths or deaths and cardiovascular events (heart attacks and stroke) combined. The first component compared intensive medical treatment with prompt coronary revascularization by either bypass surgery or angioplasty (which opens blocked arteries by inserting metal stents or balloons through the arteries, without recourse to surgery) to intensive medical treatment alone. The second component compared whether controlling diabetes with drugs to make insulin work better (insulin sensitization) had an advantage for heart health or survival compared to using a strategy emphasizing drugs increasing insulin itself (insulin provision).

Nearly 24 million Americans have diabetes, a group of serious diseases characterized by high blood glucose levels that result from defects in the body’s ability to produce and/or use insulin. Diabetes can lead to severely debilitating or fatal complications, such as heart disease, stroke, blindness, kidney disease and amputation. It is a leading cause of death by disease in the United States. Type 2 diabetes involves insulin resistance — the body’s inability to properly use its own insulin — and occurs mainly in adults who are overweight and age 40 and older. More than 65 percent of people with diabetes die from heart disease or stroke. With diabetes, heart attacks occur earlier in life and often result in death.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Oral presentation, Tuesday, 8:50 a.m.

Contact:

Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Public Health and Research

American Diabetes Association Revised Embargo for Rosiglitazone Study

Posted on June 28, 2010 Written by Editor

SOURCE: American Diabetes Association

ORLANDO, FL–(Marketwire – June 28, 2010) –  The American Diabetes Association has announced a change in the embargo time of the rosiglitazone study being presented at the 70th Scientific Session in Orlando, FL. This is part of the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) study, a landmark multicenter trial focusing exclusively on patients with both diabetes and established heart disease. The new embargo time is 4:30 pm (EDT).

The American Diabetes Association thanks the BARI 2D investigators for their collaboration and appreciates their willingness to present this important scientific information to the diabetes community during the 70th Scientific Sessions. The full scientific disclosure and discussion of these data will be featured at the Late Breaking Clinical Trials session on Tuesday, June 29, 2010 at 8:50 am.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Christine Feheley
Newsroom: 407-685-4010
Office: 703-253-4374

id=”nav_links”>

Filed Under: Public Health and Research

Artificial Pancreas Improves Overnight Glucose Control for Range of Real-Life Situations, Latest Data Show

Posted on June 27, 2010 Written by Editor

SOURCE: American Diabetes Association

Researchers Also Identify Psychosocial Barriers to Use of CGM Devices; Symposium Provides Update on Advances That Could Lead to Rapid Commercial Development of an Artificial Pancreas System

ORLANDO, FL–(Marketwire – June 27, 2010) –  Research into whether an “artificial pancreas” can effectively control blood glucose levels in children and adults with type 1 diabetes continues to make rapid advances, leading those in the field to predict that technology could become commercially available within the next few years, according to speakers at a joint American Diabetes Association — Juvenile Diabetes Research Foundation (JDRF) symposium at the Association’s 70th Scientific Sessions®.

Results, presented for the first time at today’s symposium, show that adults with type 1 diabetes can use the artificial pancreas technology to significantly improve overnight blood glucose control without increasing the risk for hypoglycemia, across a range of real-life situations — even after eating a large meal and drinking a glass of white wine. Lead researcher Roman Hovorka, Ph.D, Principal Research Associate at the University of Cambridge Metabolic Research Laboratories, noted that such a system could greatly improve the lives of those who are insulin-dependent.

A second study, also presented for the first time at the Association’s 70th Scientific Sessions, helped to identify the psychosocial characteristics of people with type 1 diabetes most likely to successfully utilize continuous glucose monitoring (CGM) devices, an important component of an artificial pancreas system. This data, presented by Marilyn Ritholz, Ph.D, Senior Psychologist at the Joslin Diabetes Center and Assistant Professor at Harvard Medical School, should help physicians and other diabetes care providers to identify patients for whom the new devices are most likely to be beneficial.

Both studies are part of the JDRF’S Artificial Pancreas Project, a partnership that brings together diabetes researchers and businesses focused on making the artificial pancreas a reality. The American Diabetes Association joined forces with JDRF at its Scientific Sessions to promote the research behind this project and to raise awareness of efforts underway to improve the lives of people with diabetes who are insulin-dependent.

“This joint symposium highlights how major organizations working together can move these technologies forward,” said Richard Bergenstal, MD, Executive Director of the International Diabetes Center and American Diabetes Association’s President, Medicine & Science. “It’s going to require collaboration between many different organizations to come together to tackle this problem.”

“It’s very exciting to work together to help people with diabetes achieve their outcomes,” said Aaron Kowalski, Ph.D, Research Director of the Artificial Pancreas Project. “We’re all interested in people with diabetes achieving better glucose control. The community needs to hear what’s happening and where we are headed.”

The JDRF research involving artificial pancreas technology combines CGM with an insulin pump and a sophisticated computer program (called an algorithm) that can automate when and how much insulin to deliver. All but the computer program are technologies already commercially available to people with diabetes. Research trials performed so far within the JDRF Artificial Pancreas Project have tested various levels of automation, multiple computer programs, and a range of in-clinic situations, including large and small meals, nighttime control, and exercise.

However, “a fully automated system that administers insulin as needed during the night without human intervention is planned to be tested on children in their homes in the United Kingdom. Nobody has done such a study before,” Hovorka said.

“I think artificial pancreas systems are going to turn out to be among the most promising short-term clinical benefits of diabetes research,” said Richard Insel, Executive Vice President of Research at JDRF. “They are going to obviously allow individuals to more effectively manage their blood glucose levels, especially after eating, when exercising, and during the night while they sleep. Not only will that help prevent long-term complications of the disease, but low blood sugars will be prevented, and living with diabetes will be easier. Just preventing the swings in glucose levels will help. The benefits are countless.”

Partially Automated Systems in Development

Hovorka and his team from the University of Cambridge have completed several recent studies of the artificial pancreas that hold promise for both children and adults with type 1 diabetes. Earlier this year, The Lancet published their landmark study of children and teenagers with type 1 diabetes who experienced better control of blood glucose levels and lower incidence of hypoglycemia while sleeping, using a closed loop artificial pancreas system.

Today, during the joint American Diabetes Association-JDRF symposium, Hovorka outlined results of his most recent study, which showed these benefits remain consistent even after adults with type 1 eat a large meal and drink a glass of white wine before bedtime. The study found that using the artificial pancreas system, these adults spent 70 percent of their time within their target blood glucose range, up from 47 percent of the time they spend within target overnight without use of the artificial pancreas system. As in the other studies, time spent in hypoglycemia tended to be reduced, even though alcohol is known to increase the risk of nocturnal/next morning hypoglycemia for people with type 1 diabetes. Full results will be presented on Monday.

The Cambridge team has also begun preliminary research into how such a system might work for pregnant women with type 1 diabetes. Early results have examined overnight glucose control in this population to establish a baseline against which they can measure effectiveness using the closed loop artificial pancreas system. These preliminary results were discussed in a poster presentation here on Saturday.

Barriers to Continuous Glucose Monitoring (CGM)

A major component of the technology needed to produce an artificial pancreas is a continuous glucose monitoring (CGM) system, which relates blood glucose levels and the direction they are trending throughout the day and night, compared to the “snapshots” that are currently taken by pricking the skin and using test strips on a periodic basis. CGM involves inserting a glucose-sensing device called a “sensor” under the skin of the abdomen, where it takes a glucose reading from the tissue every few seconds and relays it to a handheld device or insulin pump.

“CGM has the potential to be one of the most important breakthroughs in diabetes management in many years, especially for type 1, probably since pump therapies were developed in the 1980s,” said William Tamborlane, MD, of Yale University, and co-chair of JDRF’s Continuous Glucose Monitoring Group. Holding back more wide scale adoption of the technology at present, he said, are technical imperfections that make the devices cumbersome to use and require frequent calibrations and manual confirmations to ensure accuracy. “What we have now are imperfect simulations of the perfect system,” he said. But the technology holds great promise because even while not yet perfected, research has shown that using it regularly can significantly reduce A1C levels without increasing severe hypoglycemia in those who used it as directed.

JDRF-funded studies have shown that adults over the age of 25 were able to reduce their A1C levels from 7.6 to 7.1, using CGM in conjunction with an insulin pump, he said. In children ages 8-14, A1C levels dropped from 8.0 to 7.6 using CGM. Teenagers did not see a benefit, but that is likely because they were less likely to comply with using the technology than the other two groups, Tamborlane said. Participants in the trials who used the technology regularly — more than six days per week — saw similar improvement regardless of age.

“To get a benefit from a device, you actually have to use it,” he said.

Most importantly, when using CGM, A1C levels were reduced half a percentage point without increasing the risk of severe hypoglycemia, Tamborlane said. Hypoglycemia is perhaps the biggest concern for people with diabetes looking to significantly lower blood glucose levels and can have serious negative consequences, such as loss of consciousness.

The Joslin Center’s Ritholz said her team studied the psycho-social barriers that can prevent people from successful use of a CGM system and found that those who used problem-solving skills for coping with frustration and anger; who saw CGM as a mechanism for better understanding glucose patterns; and who had good support from a spouse or significant other were most likely to achieve good results with using this technology. Conversely, those who had anger and impulse control issues, who failed to synthesize the data from CGM and who didn’t have good emotional support were less likely to benefit from CGM use.

Success was defined, in this study, as lowering A1C levels by at least half a percentage point (if levels were above 7 percent at baseline) or decreasing the amount of hypoglycemia (if levels were below 7 percent at baseline), Ritholz said.

“There needs to be attention paid to the people using CGM,” she said. “We can’t just focus on the technology. In determining individualized patient care, it’s important to pay attention to who is most likely to succeed with this technology. It’s not for everybody.”

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

About JDRF
JDRF is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump — each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. The goal of the JDRF Artificial Pancreas Project is to speed the development of automated diabetes management systems. Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.4 billion to diabetes research, including more than $100 million in 20 countries last year alone.

Symposium, Sunday June 27, 2 P.M.

Contact:

Christine Feheley
(703) 253-4374

Colleen Fogarty
(703) 549-1500, ext. 2146

News Room: June 25-29, 2010
Room 303B, Orange County Convention Center
(407) 685-4010

id=”nav_links”>

Filed Under: Health Technology and AI, Public Health and Research

Bret Michaels Receives American Diabetes Association’s Chair’s Citation Award

Posted on June 25, 2010 Written by Editor

SOURCE: American Diabetes Association

Bret Michaels Presented With the Chair’s Citation Award Prior to World’s Largest Diabetes Meeting

ORLANDO, FL–(Marketwire – June 25, 2010) –  Bret Michaels, lead vocalist of Poison and winner of this season of “Celebrity Apprentice,” has received the American Diabetes Association’s prestigious Chair’s Citation Award in Orlando, FL. Bret will be the first recipient of the Award, which recognizes the outstanding accomplishments of individuals, corporations, institutions or organizations who have demonstrated significant dedication and commitment in their local market and have had a positive impact in advancing the mission of the American Diabetes Association.

“We are proud of Bret’s passion and commitment to raising funds for the American Diabetes Association. His efforts this year will truly help us change the future of this deadly disease,” said Larry Hausner, CEO, American Diabetes Association. “We are also very excited to continue our relationship with Bret and, together, help Stop DiabetesSM.”

Bret, who has type 1 diabetes, chose the American Diabetes Association as his charity during this season of “Celebrity Apprentice.” He raised $390,000 for the Association and has helped put a face to diabetes by raising critical awareness about the seriousness of diabetes and the importance of diabetes prevention and management.

The American Diabetes Association is the largest voluntary health organization committed to the fight to stop diabetes. Each year the Association honors volunteers who have made a significant contribution to this fight at its Community Volunteer Leadership Conference and National Board Meeting. Immediately following this conference, the Association hosts its Scientific Sessions with more than 13,000 top scientists, physicians and other health care professionals from around the world to share cutting edge research, treatment recommendations and advances toward a cure for diabetes.

Nearly 24 million children and adults in the United States have diabetes. Diabetes contributes to the deaths of more than 230,000 Americans each year. The American Diabetes Association estimates that the total cost of diagnosed diabetes in the United States is more than $174 billion; further published studies suggest that when additional costs for gestational diabetes, pre-diabetes and undiagnosed diabetes are included, the total diabetes-related costs in the United States could exceed $218 billion. 

About Bret Michaels
Bret Michaels, lead vocalist of Poison and winner of this season’s “Celebrity Apprentice,” has an album coming out on July 6, 2010 called “Custom Built.” Bret will also be producing and appearing in a new reality show on VH1 called “Bret Michaels: Life as You Know It.”

About the American Diabetes Association
The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Angela Murray
800-676-4065 ext. 3425
[email protected]

id=”nav_links”>

Filed Under: Healthcare Business, Public Health and Research

American Medical Association AMA Foundation Seed Grant Research Recipients

Posted on March 18, 2010 Written by Editor

The American Medical Association (AMA) Foundation has awarded medical research grants to 38 junior investigators. Established in 2000, the Seed Grant Research Program provides medical students, physician residents and fellows with grants of up to $2,500 to conduct basic science or clinical research projects.

ama-foundation

This year’s recipients are studying cardiovascular/pulmonary diseases, HIV/AIDS, leukemia, and neoplastic diseases.

The 2010 recipients are:
— Christopher Alvarez-Breckenridge, Ohio State University College of Medicine
— Hans Arora, Northwestern University
— Deanna Cettomai, MHS, Johns Hopkins University School of Medicine
— Akash Chandawarkar, Harvard Medical School
— Kevin Chen, Duke University School of Medicine
— David Clifton, University of Texas Medical Branch
— Jeffrey Costas, MS, Arizona College of Osteopathic Medicine at Midwestern University
— Andrea Dean, Yale University School of Medicine
— Dustin Deming, M.D., University of Wisconsin School of Medicine and Public Health
— Kelsey Derricks, Boston University School of Medicine
— Laura DiNardo, University of Pennsylvania School of Medicine
— Darshan Doshi, M.D., Columbia University College of Physicians and Surgeons
— Caitlin Elgarten, Columbia University College of Physicians and Surgeons
— Curtis Gabriel, Vanderbilt University School of Medicine
— Ann-Johanna Giaccone, M.D., Children’s Hospital of Philadelphia
— Allen Ho, Harvard Medical School
— Anna Kamp, M.D., MPH, University of Michigan Medical School
— Nicolas Kummer, New York Medical College
— James Lester, Edward Via Virginia College of Osteopathic Medicine
— Rung-chi Li, Ph.D., Touro University College of Osteopathic Medicine
— Ta-Chiang Liu, M.D., Ph.D., Washington University in St. Louis School of Medicine
— Su Luo, Massachusetts General Hospital
— Joshua Meisner, MS, University of Virginia School of Medicine
— Benjamin Nacev, Johns Hopkins University School of Medicine
— Michael Nguyen, MS, Saint Louis University School of Medicine
— Toral Patel, M.D., Yale University School of Medicine
— Jarrod Predina, University of Pennsylvania School of Medicine
— Greg Rice, Kansas City University of Medicine and Biosciences
— Shreyas Roy, M.D., CM, SUNY Upstate Medical University
— Lynn Rudner, University of Utah School of Medicine
— Sarah Russell, Keck School of Medicine of the University of Southern California
— Hersh Sagreiya, Stanford University School of Medicine
— Shiraj Sen, University of Texas Medical School at Houston
— Keri Seymour, DO, SUNY Upstate Medical University
— Natalie Shaw, M.D., Massachusetts General Hospital
— Preeti Sukerkar, Northwestern University
— Jesse Sulzer, Louisiana State University Medical Center
— Rabi Upadhyay, University of Massachusetts Medical School

The Seed Grant Research Program was created to encourage more physicians to consider research as a career option. Many recipients go on to publish their work, present at scientific meetings, or even secure larger grants.

The AMA Foundation supports a broad range of programs in public health and medical education. Visit www.amafoundation.org to learn more.

Source: American Medical Association Foundation

Filed Under: Hospitals and Health Systems, Public Health and Research

New Study Shows Uninsured Crisis Wildly Overestimated

Posted on June 23, 2009 Written by Editor

The Employment Policies Institute (EPI) has released the results of a new study. that shows that the “widely employed estimate of 47 million uninsured Americans is a misleading representation of the problem.”

The study, authored by Drs. June and David O’Neill of Baruch College and City University of New York, shows that more than 43 percent of uninsured Americans ages 18-64 could likely afford health coverage and are actually “voluntarily uninsured.”

Using data from a number of surveys to determine what percentage of uninsured Americans are actually unable to afford it, the study finds that at least 43 percent of Americans in the 18-64 year-old age group have incomes at least 2.5 times the poverty level and are “voluntarily” uninsured.

The study finds that 79 percent of people with incomes between 2.5 and 3.75 times the poverty level currently purchase private health insurance. In view of the large percentages covered at this level, the authors consider this uninsured group as having enough disposable income to purchase health insurance.

The uninsured population also varies dramatically from state to state. For example, thirty percent of Texas residents are uninsured, compared to 18 percent of New York and 13 percent of D.C. residents. Three states (Texas, Florida and California) make up a third of the uninsured population.

Related Coverage

  • HealthWell Opens Insurance Premium Payment Fund for Workers Who Have Been Furloughed or Laid Off
  • New Report Finds Adult Obesity Rates Increased in Six States
  • Study Finds More Obese Teens Undergoing Bariatric Surgery

For more reporting on this topic, see our Public Health and Research news hub.

Filed Under: Public Health and Research

US Healthcare System Prepared for Swine Flu

Posted on April 27, 2009 Written by Editor

The entire healthcare system in the United States is prepared for the Swine Flu if it becomes a national epidemic. Many organizations are working with the CDC in order to keep updated on the latest information about this influenza virus.

IBHS Cautions Businesses to Prepare for Flu Pandemic; Provides Free Self-Assessment Tool to Rate Readiness
The Institute for Business & Home Safety (IBHS) is cautioning businesses and nonprofit organizations to examine their ability to operate in the event of a flu pandemic.

With the federal government declaring Swine Flu a public-health emergency, IBHS says it would be wise to prepare now for the possibility of closures or other impacts a pandemic could have on operations.

“Evaluating specific risks and planning well beforehand for a variety of potential emergencies that could disrupt day-to-day business is critical, no matter how big or small a company may be,” states IBHS President and CEO Julie Rochman. “Fortunately, most catastrophes can be managed with advance, effective preparation – and that means having a well-thought out action plan with specific, appropriate policies, resources and contingencies.”

The Top 5 IBHS pandemic preparedness steps include:

1. Determine when to curtail employee travel, domestically and
internationally.
2. Develop business continuity policies that provide work-at-home options.
3. Address sick leave policies, since people with swine flu or those
attending to relatives may need to be on leave longer that the current
policy allows.
4. Consider the impact a shutdown of public transportation or the loss of
basic utilities would have.
5. Determine at what point the organization would need to close its doors.

IBHS has created a self-assessment tool for business owners and managers who can rate their readiness for a flu pandemic by answering nine basic questions. http://www.disastersafety.org/resource/resmgr/pdfs/pandemic_flu.pdf

Trust for America’s Health Applauds U.S. Response to Swine Flu
Trust for America’s Health (TFAH) today commended the Administration for its fast and effective response to the swine flu outbreak.

In order to continue to respond to this swine flu outbreak and to continue and improve preparations and the capacity to respond to other potential pandemic outbreaks, such as the H5N1 “bird flu,” TFAH recommends:

— Completing the funding to implement the National Strategy for Pandemic
Influenza. Former President Bush originally requested $7.1 billion to
carry out research and development for vaccinations, pharmaceuticals,
and medical devices needed to respond to a pandemic. $870 million of
this has never been funded. This funding was originally included in
both the FY 2008 budget and proposed 2009 stimulus bill, but was
removed each time before the bills’ final passage.
— With more than $1 billion of HHS funding, six companies are in various
stages of implementing commercial-scale production of cell-based
methods and/or expanding their vaccine capacity using eggs. By 2011,
U.S. based vaccine production capacity is expected to be at a point in
which it can generate enough pandemic influenza vaccine for every
American within six months of the time that the pandemic virus is
identified, according to the most recent Pandemic Planning Update from
HHS. However, the U.S. will not reach that capacity without completion
of the initial investment.
— Replenishing and building the Strategic National Stockpile. Purchasing
antiviral medications, vaccines, and equipment for the stockpile
should be a federal responsibility. Responding to this outbreak will
require using a significant portion of the currently stockpiled
Tamiflu(R) and other medical equipment, such as respirator masks.
These medications and equipment will need to be restocked. In
addition, the stockpile has existing shortfalls in the number of
masks, respirators, and medications needed to respond to this and
other possible pandemics, which must be completed to be prepared for
the possibility of other strains of flu.
— At the end of 2008, the Strategic National Stockpile reportedly
contained 104 million N95 respirators; 51.6 million surgical masks; 20
million syringes for pre-pandemic vaccine; 4,000 ventilators.
— Purchasing antiviral medications should become solely a federal
responsibility. Under the plan from the previous Administration,
states were expected to purchase a portion of the antiviral
medications that would be needed to protect citizens in their
states, through a program that included 25 percent subsidy from
the federal government. While the federal government has purchased
enough antivirals to cover 50 million Americans, as of October
2008, states only had purchased 22 million courses of antivirals,
which is nine million short of the goal, leaving Americans in some
states more vulnerable than others.
— Providing resources for state and local health departments to
adequately prepare for outbreaks. State and local officials are the
front line responders to outbreaks, yet they have not received any
federal funding for pandemic flu preparedness since FY 2006. $350
million is needed annually to adequately maintain state and local
pandemic preparedness activities.
— All 50 states and D.C. have a pandemic flu preparedness plan.
— All 50 states and D.C. have adequate plans to receive and
distribute emergency vaccines, antidotes, pharmaceuticals, and
medical supplies from the SNS, based on a review by CDC.
— All 50 states and D.C. have increased or maintained rates for
vaccinating adults ages 65 and older for seasonal flu, which is a
key indicator for showing how well states could vaccinate
individuals in an emergency.
— All but three states reported that their public health
laboratories meet the expectations of their state’s pandemic flu
plan (as of November 2008).

— Increase support for the Global Disease Detection (GDD) program. In
2007, the GDD program received $33.7 million in funding. If the
funding was increased to $55 million, four additional regional
detection centers could be established to improve global disease
outbreak detection and control.

Some additional ongoing challenges for pandemic preparedness that TFAH has identified in recent analyses include:

— Maintaining real-time disease detection and surveillance capabilities;
— Managing mass casualty care if there is a major surge in patients at
hospitals and treatment facilities;
— Ensuring the ability to swiftly and safely distribute and administer
medical treatments and vaccines;
— Reaching and providing special services for at-risk and vulnerable
populations, including children, the elderly, and low-income
communities;
— Bolstering the public health workforce with enough experts and
officials, many state and local health departments have experienced
workforce cuts during the recession; and

— Protecting health officials and volunteer medical providers during
emergencies.

TFAH’s annual health emergency preparedness report, Ready or Not? Protecting the Public’s Health from Diseases, Disasters, and Bioterrorism, and a report that examined the potential impact of a severe pandemic outbreak, Pandemic Flu and the Potential for U.S. Economic Recession, are available on TFAH’s Web site: www.healthyamericans.org. Also, brochures about how individuals, businesses, community-based organizations and the medical community are available at the Web site.

Trust for America’s Health is a non-profit, non-partisan organization dedicated to saving lives by protecting the health of every community and working to make disease prevention a national priority.

Travellers to Mexico so far Undeterred by Swine Flu Outbreak
Data from leading flight search company Skyscanner (http://www.Skyscanner.net) shows that travellers planning trips to Mexico have so far been undeterred by the outbreak of swine flu influenza announced by Mexico’s Federal Health Ministry on the 22nd April.

“Dire predictions have already been made about the impact that this will have on tourism, but the number of Skyscanner users searching for flights to Mexico has remained stable in the days since news emerged of the outbreak,” said Skyscanner director and co-founder Barry Smith.

“We would have expected to see some negative impact by now, but it may be that travellers are reassured by the fact that the outbreak is largely concentrated in Mexico City – a two hour flight from the coastal resorts – and by the fact that the Foreign Office, World Health Organisation and the US Center for Disease Control and Prevention have not yet made recommendations that people stay away. We’ll get a clearer picture in the next few days as the news spreads and the implications for travellers are fully understood.”

Skyscanner is the most powerful and flexible flight search engine in Europe, providing instant online comparison on flight prices for over 670,000 routes on over 600 airlines. With Skyscanner, users can browse without having to enter specific dates or even destinations, and Skyscanner is available in 20 different languages including French, German and Spanish.

Swine Flu: Infection Control in Hospitals Will Be Critical
In response to confirmed cases of swine flu in Mexico, Canada, and the United States, European Union health officials are advising against travel to North America. At airports in Japan and several other Asian countries, thermal scanners are being used to identify fever among passengers from North America.

But in the U.S. the disease is already among us. The severity and extent are unknown. The SARS outbreak (severe acute respiratory syndrome) in 2003 teaches that rigorous infection control in hospitals may be key to limiting deaths from swine flu in the U.S. Much will depend on what hospitals do when the first seriously ill victims arrive.” If hospitals have effective infection controls in place, the disease can be prevented from spreading to visitors, healthcare workers and their families,” warns Betsy McCaughey, Ph.D., and Chairman of the Committee to Reduce Infection Deaths (RID), a national organization that educates the public and medical community about preventing infection. McCaughey explains that “77% of the people who contracted SARS in the Canadian outbreak were patients, visitors or workers in hospitals. SARS was almost entirely a hospital infection epidemic.”

SARS — four letters that filled the headlines in the spring of 2003, and then disappeared. “A report issued after the fact by the government of Ontario (The SARS Commission, Spring of Fear, December 2006) shows how hospitals in one city thwarted an epidemic while hospitals in another city made deadly mistakes” says McCaughey, an expert on preventing infection.

Many hospitals in the U.S. are under-prepared for a similar challenge. As many as ten percent of patients contract infections in the hospital, according to the Centers for Disease Control and Prevention. Bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and Clostridium difficile race through hospitals, spread by unwashed hands and unclean equipment. How can hospitals that are failing to prevent ordinary infections spread by touch contain a new, unknown virus that can spread whenever someone coughs or sneezes?

“The best defense against swine flu and other unknown pathogens is rigorous hospital hygiene and routine infection prevention. That is the lesson of SARS,” says McCaughey.

Dr. McCaughey is available to speak about the precautions that should be taken in hospitals, schools, day care centers, nursing homes and other places where the disease can spread easily.

Betsy McCaughey, Ph.D., is founder of the Committee to Reduce Infection Deaths and former Lt. Governor of New York State.

http://www.hospitalinfection.org/

Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu
The Commonwealth of Pennsylvania is working with federal officials to contain the impact of an outbreak of swine flu in Mexico that resulted in the declaration of a national public health emergency in the United States.

The Department of Health is working to educate the public and health care providers of recommended steps to prepare for potential cases of swine influenza in Pennsylvania.

The Department of Health has notified health care providers across Pennsylvania to be watchful for patients with influenza-like illness who may have been exposed to the new swine flu strain and to immediately inform the local health department of any suspected cases. The department will assist all health care providers in evaluating the patients, recommending control measures, and assisting in specimen collection and testing when indicated.

This notification follows confirmation of a new strain of swine influenza A/H1N1 virus in Mexico and five locations in the U.S., including New York and Ohio. To date, all U.S. cases were “mild” with only one person requiring brief hospitalization.

According to the U.S. Centers for Disease Control and Prevention, swine influenza A/H1N1 is a new strain of influenza that has not previously been detected in swine or humans. The virus has also been confirmed in Canada and Mexico. It is still safe to eat pork and pork products.

The Department of Health provided information to all of the state’s health care providers and hospitals late Friday regarding the swine flu, including how to quickly report possible cases and how to submit samples for testing. Anyone who has traveled to or from the affected areas and has a respiratory illness should contact their health care provider or local health department before seeking health care.

Swine influenza is a respiratory disease of pigs caused by type A influenza viruses. Outbreaks of swine flu happen regularly in pigs. Before the current outbreak, people rarely got swine flu, and usually only if they were in very close proximity to infected pigs. However, during the current outbreak, the virus is able to spread from person-to-person.

Symptoms of swine flu in people are similar to those of regular or seasonal flu and include fever, lethargy, lack of appetite and coughing. Some with swine flu also have reported runny nose, sore throat, nausea, vomiting and diarrhea. Although winter is over, there is still a low level of seasonal influenza occurring in the state.

There is no vaccine available at this time, but the swine flu can be treated with certain antiviral drugs. Persons with swine flu are contagious for up to seven days or longer after the onset of illness, so it is important to take the following steps to prevent spreading the virus to others:

— Stay home when you are sick to avoid spreading illness to others;
— Cough or sneeze into the bend of your elbow or a tissue and properly
dispose of used tissues;
— Wash your hands frequently and thoroughly with soap and warm water or
use an alcohol-based hand sanitizer;
— Avoid touching your eyes, nose and mouth;
— Stay healthy by eating a balanced diet, drinking plenty of water and
getting plenty of rest and exercise; and
— Seek care if you have influenza-like illness.

The CDC is asking that those individuals who have a recent history of travel and experience mild, flu-like symptoms to stay home. However, if you feel your symptoms worsen or become severe, call or visit your health care provider.

For more information on Swine Influenza A/H1N1, contact the Department of Health at 1-877-PA-HEALTH or visit www.health.state.pa.us.

Related Coverage

  • Secretary of Health Urges U.S. Legislators to Consider How Repealing ACA Could Eliminate Critical Health Funding for the Commonwealth
  • Top 10 COVID-19 Vaccine Questions
  • Tencent’s WeSure Unveils New initiative for Cured COVID-19 Patients

For more reporting on this topic, see our Public Health and Research news hub.

Filed Under: Public Health and Research

Study Finds More Obese Teens Undergoing Bariatric Surgery

Posted on March 2, 2007 Written by Editor

At a time when there are growing concerns about a national epidemic of obesity among teenagers, a new study focusing on morbidly obese teens who have last-resort bariatric surgery has found that the procedure poses no greater risks for them than for adult patients, and that, in fact, they have a zero death rate and a faster rate of recovery than older patients.

Gastric bypass, stapling or similar procedures known as bariatric surgery is an approach to weight management for morbidly obese patients, which has documented results in improved health outcomes for adults.

Now researchers at the Robert Wood Johnson Medical School and Cincinnati Children’s Hospital Medical Center have used data from a large national database to examine nationwide trends from 1996 to 2003 in the use of adolescent bariatric surgery in the first effort to compare the early postoperative results following bariatric surgery in adolescents and adults.

The study, published in the March issue of Archives of Pediatrics & Adolescent Medicine, shows that surgery among teens has tripled in recent years, increasing in the U.S. from an estimate of just over 200 procedures in 2000 to almost 800 procedures in 2003.

The new study also compared the costs of surgery for adults and teens, finding that adolescents had lower hospital charges. Total hospital charges in 2003 for adolescents undergoing bariatric surgery were $23.6 million and for adults was $3.8 billion. The average hospital charges associated with these procedures were 15 percent lower for adolescents than for adults. Similar to adults, most adolescents had private insurance.

Although bariatric surgery among adolescents has increased, it is by no means a common procedure, representing fewer than one percent of the bariatric procedures performed nationwide. The study found that although the majority of surgery recipients are female, more male adolescents are requesting it.

Related Coverage

  • Usage of Telehealth and Retail Clinics Grew from 2017 to 2018 While That of ERs, ASCs and Urgent Care Declined
  • A Safer CAR-T Breakthrough? BioOra and Cincinnati Children’s Target Childhood Leukemia
  • Study Reveals Most Kids Hospitalized for Allergic Reactions Could Be Home in Two Hours

For more reporting on this topic, see our Hospitals and Health Systems news hub.

Filed Under: Hospitals and Health Systems, Public Health and Research

Acupressure Technique is Credited with Relieving Prostate Cancer Symptoms

Posted on October 18, 2006 Written by Editor

In May 2004, Jonas Slonaker participated in a nine-day, on-camera retreat to focus on using Emotional Freedom Techniques (EFT) to address his symptoms of prostate cancer. He continues to do EFT daily; and today he is still free of any cancer symptoms, and his last three PSA (prostate-specific antigen) counts were “barely over two.”

EFT involves fingertip tapping on select acupressure points while focusing on the physical symptom or unresolved emotion in question. EFT claims an 80% success rate in calming symptoms associated with serious diseases like cancer. It can be learned without cost by downloading the free EFT Manual here.

“What is remarkable about using EFT for serious diseases,” says EFT Founder Gary Craig, “is that when we persistently address unresolved emotional issues and traumas, the symptoms associated with the disease tend to fade … often permanently. In Jonas’s case, he was harboring a deep and unresolved anger at his abusive father. In about 40 minutes of doing EFT together, he no longer felt the explosive anger towards his father.”

Jonas reports, “I urinate just fine and have no pain down there. I stopped taking the medication that helped me urinate. My story is simple. I use EFT everyday to release emotional energy blocks in my system. If I don’t have a particular issue or emotion to release, then I tap and sing the word Love over and over. I tap every morning for fifteen minutes to get my day started. Then I tap whenever the need arises. If someone snaps at me at work, I tap and let that go before it can become a repetitive resentment. Many of the times when I tap, I go into a deep state of peace and now and again I experience radiant joy. EFT helped me reach a place of great love and acceptance and I honestly don’t believe the cancer can survive in that environment.”

To witness Jonas’s on-camera EFT session, the combined set of DVD’s, which contains 40 hours of instruction and demonstrations, costs only $72 at https://www.emofree.com/Store/store.aspx.

More than a decade of reports from thousands of EFT users has convinced Craig of the connection between people’s unresolved emotions and their physical issues. Now an increasing number of medical studies are making the same connections, but EFT claims to offer a simple solution to resolving the emotional component of disease.

Craig says, “We are not advocating that people adopt EFT instead of conventional medicine to treat serious diseases. But medical research is consistently showing that unresolved emotional traumas, anger, and resentment contribute to disease. EFT provides a drug-free way for people to permanently clear the unresolved emotions that are disrupting their energy systems, taxing their immune systems and causing disease.”

Belgian physician Dr. Tania de Winne uses EFT in her medical practice and sees consistent evidence of the mind-body connection with her patients. “While I have no proof that EFT prevents cancer,” she says, “I’m convinced that it does just that. Negative thoughts are a major cause of not just cancer but all illnesses, and since EFT quickly eliminates the energy blocks that contribute to negative thoughts and emotions, I believe cancer and most other diseases can ultimately be eradicated by using EFT on a daily basis.”

According to the National Institutes of Health, about 1500 people in the U.S. die of cancer each day and another 3400 are diagnosed with cancer daily. “In my view,” says Craig, “people are dying needlessly from unresolved emotions like anger, fear, guilt and resentment.”

Physician, Dr. Eric Robins adds, “Some day the medical profession will wake up and realize that unresolved emotional issues are the main cause of 85% of all illnesses. When they do, EFT will be one of their primary healing tools …. as it is for me.”

EFT is still a new procedure, but already over 350,000 — including thousands of health care practitioners have downloaded Craig’s free training manual and another 10,000 download it each month. EFT often works when nothing else will, even on serious diseases like cancer. Word of mouth is making EFT a top self-healing modality. The EFT website is the fifth most actively visited natural health site in the world.

The EFT Manual gives anyone all the basics so they can apply it right away. It can be freely downloaded here.

Related Coverage

  • Acupressure Technique Relieves Huntington’s Disease Symptoms
  • Lap-Band Success: 1-800-GET-THIN Reports On a Woman Who Lost 100 LBS.

For more reporting on this topic, see our Public Health and Research news hub.

Filed Under: Public Health and Research

Acupressure Technique Relieves Huntington’s Disease Symptoms

Posted on July 17, 2006 Written by Editor

While researchers have spent ten years developing a cure for Huntington’s Disease (HD) in mice, people suffering with the disease have gained symptom relief with a simple do-it-yourself acupressure technique. According to the theory behind Emotional Freedom Techniques (EFT), illness and disease are caused by unresolved emotional issues and a disrupted energy meridian system (Chi or Qi). When emotional issues are resolved using EFT, physical symptoms associated with serious diseases have been shown to clear, sometimes immediately and often permanently.

EFT is a do-it-yourself acupressure technique that anybody can use to provide relief from the physical and emotional symptoms associated with HD. It involves fingertip tapping on select acupressure points while focusing on the symptom in question. EFT claims an 80% success rate in calming symptoms associated with serious diseases.

It and can be learned freely by downloading the EFT Manual at http://www.emofree.com/downloadeftmanual.asp?ref=prwHDcw

Researchers from the University of British Columbia have found a way to block the enzyme believed to be instrumental in the development of the disease. For the next five years, researchers will focus on developing and testing a drug that will achieve the same results in humans.

In the meantime, EFT is giving HD patients drug-free relief from the symptoms associated with this degenerative brain disease. EFT theory takes a very different approach to addressing symptoms associated with such diseases.

According to Gary Craig, the Stanford-trained engineer who developed EFT, “When EFT Practitioners approach serious diseases such as Huntington’s, we look at the person’s symptoms and the emotions associated with their symptoms. When we address illness-related emotions like fear, frustration, and grief, we repeatedly find that the symptoms subside, even disappear.”

Children of HD patients have a 50% chance of inheriting Huntington’s. If they have inherited the disease, symptoms generally appear later in life. “I can’t help but wonder whether applying EFT could postpone or even suspend the development of symptoms,” says Craig.

Diane Kendrick is an EFT Practitioner in the United Kingdom whose client had Huntington’s disease. The client presented as having a phobia about walking down stairs, but her HD was evidenced in her slurred speech, jerky gait, twitching and labored breathing.

Because of her symptoms, the woman had difficulty tapping the EFT points, so had her husband do it for her. When she returned a week later, Diane was surprised, “I couldn’t believe the changes in her. Her visual symptoms were about 60% improved.” Her jerkiness and twitching had subsided and her communication had improved. Her speech was less slurred and more clear. During the week between appointments, the woman had done EFT tapping every day on her own. It had become increasingly easy to do as her coordination and enthusiasm had improved.

They did a little more EFT for the phobia of stairs and the woman pinpointed having fallen down stairs ten years previously. With five minutes of EFT, she went up and down stairs with no trace of fear or anxiety. The phobia was gone, but more importantly, she had a considerable improvement in several of the symptoms associated with her incurable physical condition.

Craig explains, “We see this repeatedly with EFT, where addressing a specific issue like a phobia has a generalized positive result for the person’s health. We are not claiming that EFT cures diseases, but EFT users all over the world have experienced remarkable results in the reduction of symptoms associated with cancer, diabetes, Parkinson’s disease, Crohn’s disease, lupus, Alzheimer’s disease, MS, arthritis and others. Fortunately, an increasing number of health professionals are incorporating EFT into their medical practices.”

There are no known side effects associated with EFT and it often gives symptom relief where nothing else works. “It is my goal,” says Craig, “to encourage the use of EFT to compliment any medical protocol employed to treat serious diseases. To this end, I make the EFT Manual available freely on the EFT website.”

Although most Americans have yet to hear of it, EFT may be the world’s fastest-growing self-help technique. Over 300,000 have downloaded Craig’s free training manual and another 10,000 download it each month. The official EFT Manual has been translated by volunteer practitioners into nine languages.

The EFT Manual explains the basics so that anyone can begin applying EFT right away. It can be freely downloaded at
http://www.emofree.com/downloadeftmanual.asp?ref=prwHDcw

For further information, contact Gary Craig at 707-785-2848.

Related Coverage

  • Acupressure Technique is Credited with Relieving Prostate Cancer Symptoms
  • Lap-Band Success: 1-800-GET-THIN Reports On a Woman Who Lost 100 LBS.

For more reporting on this topic, see our Public Health and Research news hub.

Filed Under: Public Health and Research

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8

Search Our Site

Categories

  • Blue Cross Blue Shield
  • Health Insurance Companies
  • Health Insurance Coverage
  • Health Technology and AI
  • Healthcare Business
  • Healthcare Policy and Law
  • Hospitals and Health Systems
  • Medicaid and CHIP
  • Medicare
  • Prescription Drugs and Pharmacy
  • Public Health and Research
  • Senior Care

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer